Oncternal Therapeutics, Inc. Skyrocketed

Thu, Nov 05, 2020 at 05:30 PM
Oncternal Therapeutics, Inc. Skyrocketed

Oncternal Therapeutics, Inc. (ONCT:NASDAQ) soared at $3.36, a gain of 122.5%. On Wed 04 Nov 20, ONCT:NASDAQ touched a New 2-Week Low of $1.51. The stock got featured on our News Catalysts scanner on Wed 04 Nov 20 at 07:15 PM in the 'INVESTOR UPDATE' category. From Wed 21 Oct 20, the stock recorded 30.00% Up Days and 18.18% Green Days

The share price of the company has been moving sideways in recent weeks.

About Oncternal Therapeutics, Inc. (ONCT:NASDAQ)

GTx Inc is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of small molecules for the treatment of cancer including treatment of breast and prostate cancer and other serious medical conditions such as Stress urinary incontinence and Duchenne muscular dystrophy. Its lead product candidate is Enobosarm. The company's strategy is focused on the further development of selective androgen receptor modulators.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.